Perelman School of Medicine

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from antiretroviral therapy (ART) to treat HIV.

Steve Graff ・March 17, 2014

WHO:             Women of Color at Penn                       University of Pennsylvania

Jacquie Posey March 13, 2014

Babies are born with the ability to digest lactose, the sugar found in milk, but most humans lose this ability after infancy because of declining levels of the lactose-digesting enzyme lactase.

Katherine Unger Baillie ・March 13, 2014

“Cell movement is the basic recipe of life, and all cells have the capacity to move,” says Roberto Dominguez, PhD, professor of Physiology at the Perelman School of Medicine, University of Pennsylvania.

Karen Kreeger ・March 12, 2014

In 2010, scientists in Italy reported that a woman and her daughter showed a puzzling array of disabilities, including epilepsy and cleft palate. The mother had previously lost a 15-day-old son to respiratory failure, and the research team noted that the mother and daughter were missing a large chunk of DNA on their X chromosome.

Katherine Unger Baillie ・March 11, 2014

Even the mildest form of a traumatic brain injury, better known as a concussion, can deal permanent, irreparable damage. Now, an interdisciplinary team of researchers at the University of Pennsylvania is using mathematical modeling to better understand the mechanisms at play in this kind of injury, with an eye toward protecting the brain from its long-term consequences.

Evan Lerner ・March 5, 2014

University of Pennsylvania researchers have successfully genetically engineered the immune cells of 12 HIV positive patients to resist infection, and decreased the viral loads of some patients taken off antiretroviral drug therapy (ADT) entirely—including one patient whose levels became undetectable.

Steve Graff ・March 5, 2014